Background Despite significant advances in breast cancer control and survival with
endocrine therapies (ETs), treatment utilization and outcomes in developing countries have …

Many cities around the world have adopted dockless bike-sharing programs with the hope
that this new service could enhance last-mile public transit connections. However, our …

Rationale: Men and postmenopausal women are more prone to developing non-alcoholic
fatty liver disease/steatohepatitis (NAFLD/NASH) than premenopausal women. However …

Metabolic syndrome, which is extremely common in developed and some developing
countries, is a clustering of at least three of five of the following medical conditions …

Estrogen receptor alpha (ERα) acts as the transcription factor and the main therapeutic
target against breast cancer. One of the compounds that has been shown to act as an ERα is …

Abstract Background Tamoxifen (TAM) and Toremifene (TOR), two kinds of selective
estrogen receptor modulators (SERMs), have equal efficacy in breast cancer patients …

Abstract Background & Aims Tamoxifen is associated with an increased risk of developing
fatty liver. The aim of this systematic review and meta‐analysis was to evaluate the …

The relationship between non-alcoholic fatty liver disease (NAFLD) and triple-negative
breast cancer (TNBC) has been widely recognized, but the underlying mechanisms are still …

Nonalcoholic fatty liver disease (NAFLD) encompasses the entire spectrum of fatty liver
disease in individuals without significant alcohol consumption, including isolated steatosis …

Purpose To investigate the relationship between tamoxifen-associated nonalcoholic fatty
liver disease (NAFLD) and survival outcomes in patients with breast cancer. Methods …